As a new foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply transglutaminase sourced directly from multiple well-known original manufacturers.
As a foreign trade enterprise with independent R&D capabilities, HiSiaddi does not only promote its own factory’s products like single-brand manufacturers. We objectively analyze multiple top market-share brands in China and worldwide, sharing their landmark process advancements and breakthroughs to provide buyers with authentic, up-to-date market intelligence.
If you require more comprehensive and valuable transglutaminase market insights, please contact HiSiaddi customer service.
1. Breakthrough Metrics: The five leading domestic manufacturers completed site-directed gene modification of Streptomyces mobaraensis strains, boosting TG enzyme output per unit bacterial biomass in fermenters by 27% and cutting grain consumption for fermentation raw materials by 17.2%. Dongsheng Bio mass-produced proprietary non-GMO patented strains (CCTCC M2020197), with total heterotrophic bacteria residual <10CFU/g across all product lines—3x stricter than national standards and matching top international benchmarks.
2. Commercial Application: Ex-factory prices for all solid TG enzyme ranges fell 14.8% year-on-year compared to 2023.
3. Buyer Benefits: Unit procurement prices for equivalent enzyme activity decreased by 12%–16%, with further raw material cost compression for bulk consolidated orders. Low heterotrophic bacteria levels meet EU and North American food entry standards, reducing risks of customs inspection detention in importing nations.
1. Breakthrough Metrics: Starting in 2025, mass production of 220–300U/g ultra-high-activity TG was realized (previously domestic mainstream maximum capped at 180U/g). The coefficient of variation (CV) for batch enzyme activity dropped from the traditional 11% to ≤3.5%, resolving the long-standing pain point of inconsistent domestic batch activity. Economical low-activity grades (50–80U/g) were optimized to widen pH tolerance to 4.2–9.0.
2. Commercial Application: Ultra-high-activity TG targets plant-based meat analogs and high-protein meal replacements; low-activity variants serve chilled fresh meat products and quick-frozen dough foods.
3. Buyer Benefits: Ultra-high-activity TG reduces required dosage from the standard 0.35% to 0.12%, cutting downstream raw material feeding costs by 22%. A single grade fits multiple production lines, reducing SKU inventory variety and warehouse storage overhead.
1. Breakthrough Metrics: Yiming Bio and Qingrui Bio completed cold-resistant modification of liquid TG, expanding applicable processing temperatures from the previous minimum of 8°C down to 0–4°C cold chain production. After 6 months of storage at 4°C, ≥92% of enzyme activity is retained (conventional liquid TG loses over 30% activity after just 3 months refrigeration).
2. Commercial Application: Exclusively formulated for chilled yogurt, cold restructured sashimi, and ready-to-eat chilled ham.
3. Buyer Benefits: No high-temperature feeding equipment retrofits are required for existing low-temperature production lines, eliminating factory modification costs. Liquid formulations deliver uniform dosing, cutting manual labor waste on automated production lines by 8%.
1. Breakthrough Metrics: Dongsheng Bio and Yuntai Bio developed phosphate-free compound TG formulations that replace phosphate-based water retention structures in meat products, containing no sodium pyrophosphate or sodium tripolyphosphate while maintaining finished meat water retention ≥91%—matching performance of phosphate-containing alternatives.
2. Commercial Application: Low-salt meat products, organic baked goods, and infant complementary food raw materials.
3. Buyer Benefits: End products may carry "no added phosphate" labeling to qualify for EU organic food market access, delivering an 8%–15% price premium for end goods and expanding distribution channels to high-end supermarkets.
1. Breakthrough Metrics: Donghui Bio partnered with Bloomage Bio to export medical-grade TG with residual protein impurities <5ppm and heavy metal lead/arsenic levels <0.01mg/kg. Full product lines hold dual EU EFSA and US FDA GRAS certifications, enabling large-scale domestic medical TG exports (previously medical-grade TG relied almost entirely on Japanese brand imports).
2. Commercial Application: Medical tissue adhesion, cosmetic collagen crosslinking, and in vitro biological reagents.
3. Buyer Benefits: Raw material procurement costs for medical applications are reduced by 35% versus imported foreign brands, breaking overseas monopolies on medical raw materials.
1. Breakthrough Metrics: The new 2025 TG-B modified series delivers targeted crosslinking for pea and soy isolate proteins, raising plant protein fiber formation rates by 18%. Tolerable salt concentration limits for TG increased from 3% to 6%, compatible with high-salt cured meat and Western salami manufacturing.
2. Commercial Application: Premium plant-based steak and fermented cured meat products.
3. Buyer Benefits: Utilization rate of plant meat trimmings rose from 78% to 93%, cutting scrap losses and boosting end-product yield by 9%. No additional compound additives are required for high-salt environments, simplifying formula R&D workflows.
1. Breakthrough Metrics: Mass production of food-grade carrier-immobilized TG enables filtration recovery after single catalytic use, with ≥82% residual effective enzyme activity and ≥5 reuse cycles. Immobilized TG withstands temperatures up to 72°C without rapid deactivation during high-temperature meat cooking (conventional TG loses activity sharply above 55°C).
2. Commercial Application: Continuous large-scale ham production lines and automated canned meat processing workflows.
3. Buyer Benefits: TG raw material consumption per ton of finished goods drops by 60%, drastically compressing raw material expenses for large-scale manufacturers. Heat resistance accommodates high-temperature sterilization processes, reducing canned product breakage rates from 7.2% to 1.1%.
1. Breakthrough Metrics: The TGP-A new TG series retains >88% enzyme activity in pH 3.0–4.5 acidic yogurt and fruit dairy beverage systems, resolving the longstanding issue of rapid TG deactivation under acidic conditions. Whey separation rates in yogurt decreased from 8.3% to <1.8%.
2. Commercial Application: Ambient-temperature acidic dairy drinks, fruit yogurt, and fermented cheese.
3. Buyer Benefits: Formulations reduce gelatin, pectin, and other stabilizer dosages by 40%, cutting auxiliary material procurement costs. End beverage shelf life extends by 30 days, lowering channel losses from expired inventory.
1. Breakthrough Metrics: Optimized compound formulas combining TG and glucose oxidase raise gluten crosslink density in dough by 22%, extending ambient anti-staling shelf life of finished bread from 5 days to 7.2 days. After 3 freeze-thaw cycles for frozen dough, gluten damage rates remain below 5%.
2. Commercial Application: Frozen dough, European-style bread, and quick-frozen steamed buns and flour products.
3. Buyer Benefits: Bakers reduce preservative dosages to align with Clean Label trends. Frozen dough scrap loss rates decline by 65%, drastically cutting downstream inventory waste.
1. Breakthrough Metrics: Industrial mass production of the Andracon® gene-recombinant TG delivers ≥99.5% medicinal purity with no heteroprotein or animal-derived residues, applied to ADC antibody drug conjugation and celiac disease targeted pharmaceutical intermediates. The product entered Phase II clinical supply chains for European and American pharmaceutical companies in 2026.
2. Commercial Application: Biopharmaceuticals and premium cosmetic collagen filler raw materials.
3. Buyer Benefits: Pharmaceutical and cosmetic raw material importers access bulk localized sourcing, with raw material unit prices reduced by 28% and delivery lead times shortened from 45 days to 12 days versus historical lab-scale small-batch procurement.
1. Clean Label Compliance Advantages: All leading domestic and foreign manufacturers completed non-GMO and allergen-free strain modifications, with full product lines satisfying mainstream food regulations across the EU, US, and Australia. Buyers can smoothly clear customs in most global markets and avoid fines for non-compliant labeling.
2. Formulation Cost Reduction Advantages: Widespread adoption of high-activity TG cuts average required dosages by approximately 30%, lowering raw material costs by 8%–25% across three core downstream sectors: meat products, dairy goods, and plant-based alternatives.
3. Product Iteration Advantages: A full spectrum of specialized TG grades optimized for low-temperature, high-salt, acidic, and immobilized applications fills market gaps. Buyers select custom specialized grades rather than compromising production lines with universal TG, shortening new product R&D cycles by 40%.
If you require more comprehensive and valuable transglutaminase market insights, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
